Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
NPJ Precision Oncology|September 7, 2023
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progressionVipin Shankar Chelakkot, Kiara Thomas, Todd Romigh, et al.
Journal for Immunotherapy of Cancer|May 17, 2018
Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case seriesLillian Sun, Pauline Funchain, Jung Min Song, et al.
JCO Precision Oncology|February 1, 2022
Primer on Hereditary Cancer Predisposition Genes Included Within Somatic Next-Generation Sequencing PanelsZade Akras, Brandon Bungo, Brandie H Leach, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 15, 2025
Beyond Checkpoint Inhibition: Keeping Therapeutic Options OpenUrvashi Mitbander Joshi, Jasmin Hundal, Jonaphine R Mata, et al.
Genome Medicine|February 9, 2017
Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomasHannah Wang, Pauline Funchain, Gurkan Bebek, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Genetics|September 21, 2002
Escherichia coli strains (ndk) lacking nucleoside diphosphate kinase are powerful mutators for base substitutions and frameshifts in mismatch-repair-deficient strainsJeffrey H Miller, Pauline Funchain, Wendy Clendenin, et al.
Cancer Medicine|July 20, 2024
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapiesDanai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, et al.
Targeted Oncology|August 20, 2022
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint InhibitorsIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Gastroenterology Research|May 16, 2022
Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved SurvivalMohammad Alomari, Suleiman Al Ashi, Pravallika Chadalavada, et al.
Pageof 9